Comparison 76. SE ‐ Sleepiness/somnolence.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Citalopram versus TCAs	5	966	Odds Ratio (M‐H, Random, 95% CI)	0.49 [0.33, 0.74]
1.1 versus Amitriptyline	2	416	Odds Ratio (M‐H, Random, 95% CI)	0.45 [0.24, 0.85]
1.2 versus Imipramine	2	515	Odds Ratio (M‐H, Random, 95% CI)	0.48 [0.27, 0.83]
1.3 versus Nortriptyline	1	35	Odds Ratio (M‐H, Random, 95% CI)	0.9 [0.24, 3.41]
2 Citalopram versus heterocyclics	1	336	Odds Ratio (M‐H, Random, 95% CI)	0.20 [0.04, 0.94]
2.1 versus Mianserin	1	336	Odds Ratio (M‐H, Random, 95% CI)	0.20 [0.04, 0.94]
3 Citalopram versus other SSRIs	7		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
3.1 Versus Escitalopram	3	859	Odds Ratio (M‐H, Random, 95% CI)	0.75 [0.34, 1.64]
3.2 Versus Fluoxetine	1	316	Odds Ratio (M‐H, Random, 95% CI)	1.42 [0.44, 4.57]
3.3 Versus Paroxetine	1	406	Odds Ratio (M‐H, Random, 95% CI)	1.64 [0.92, 2.90]
3.4 Versus Sertraline	2	442	Odds Ratio (M‐H, Random, 95% CI)	0.68 [0.31, 1.51]
4 Citalopram versus MAOIs or newer ADs	1	42	Odds Ratio (M‐H, Random, 95% CI)	2.86 [0.11, 74.31]
4.1 versus Moclobemide	1	42	Odds Ratio (M‐H, Random, 95% CI)	2.86 [0.11, 74.31]
5 Citalopram versus other conventional ADs	1	357	Odds Ratio (M‐H, Random, 95% CI)	2.46 [0.63, 9.66]
5.1 versus Reboxetine	1	357	Odds Ratio (M‐H, Random, 95% CI)	2.46 [0.63, 9.66]